Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Chief Technology Officer | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,967 |
Reported balance
After 2026-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 31,993 · Balance 87,967 F1: 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
| Common StockSEC Table I · non-derivative | Direct | 73,807 |
Reported balance
After 2026-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-17 · Tax withholding · Disposed 14,160 · Balance 73,807 |
| Common StockSEC Table I · non-derivative | Direct | 64,891 |
Reported balance
After 2026-02-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-02-17 · Sale · Disposed 8,916 · Balance 64,891 |
| Common StockSEC Table I · non-derivative | Direct | 61,283 |
Reported balance
After 2026-02-17 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-02-17 · Tax withholding · Disposed 3,608 · Balance 61,283 |
| Common StockSEC Table I · non-derivative | Direct | 58,951 |
Reported balance
After 2026-02-17 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-02-17 · Sale · Disposed 2,332 · Balance 58,951 |
| Common StockSEC Table I · non-derivative | Direct | 73,904 |
Reported balance
After 2026-02-19 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-02-19 · Grant · Acquired 14,953 · Balance 73,904 F3: These shares vest 100% three years from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan
F3: These shares vest 100% three years from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 14,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 6 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,904 F3 · kind: These shares vest 100% three years from grant award date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,332 | $24.82 | $57,880.24 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 5 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,951 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 3,608 | $24.89 | $89,803.12 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 4 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,283 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,916 | $24.82 | $221,295.12 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,891 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 14,160 | $24.89 | $352,442.40 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,807 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:40 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 31,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001731934-26-000002 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,967 F1 · kind: 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 16:07 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 12,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001458 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,595 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 3,259 | $24.62 | $80,246.36 |
DisclosureSEC source: 0001562180-25-001300 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,332 F3 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 6,276 | $24.62 | $154,533.95 |
DisclosureSEC source: 0001562180-25-001300 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,591 F3 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:11 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 13,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001300 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,867 F1 · kind: 13,085 shares are performance based shares where the total number of shares granted were based on long term performance incentives. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:02 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 6,456 | $35.01 | $226,031.66 |
DisclosureSEC source: 0001562180-24-001468 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,497 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:02 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 8,878 | $35.01 | $310,828.55 |
DisclosureSEC source: 0001562180-24-001468 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,953 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:02 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001468 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,831 F1 · kind: 8,878 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 19:38 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 9,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001368 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,953 F1 · shares: These shares vest 100% three years from grant award date. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 20:11 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 1,242 | $0.00 Strike: $15.69 | $0.00 |
DisclosureSEC source: 0001562180-23-002535 · primarydocument.xml · derivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,242 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 20:11 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,242 | $28.41 | $35,285.22 |
DisclosureSEC source: 0001562180-23-002535 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,176 Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 20:11 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 1,242 | $15.69 | $19,486.98 |
DisclosureSEC source: 0001562180-23-002535 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:19 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,632 | $28.65 | $75,406.80 |
DisclosureSEC source: 0001562180-23-001569 · primarydocument.xml · nonDerivative · entry 4 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,176 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:19 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 3,527 | $28.65 | $101,048.55 |
DisclosureSEC source: 0001562180-23-001569 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,808 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:19 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 7,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001569 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,335 F3 · kind: 7,772 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 20:19 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001569 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,563 F1 · shares: These shares vest 100% three years from grant award date. F2 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 12:18 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,500 | $29.24 | $131,579.55 |
DisclosureSEC source: 0001562180-22-003046 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,022 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.05 to $29.45. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 74 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 10,228 | $30.36 | $310,546.63 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,448 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 10,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,676 F3 · kind: 10,228 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:01 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,765 | $30.36 | $175,039.24 |
DisclosureSEC source: 0001562180-22-001717 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,448 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:14 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 7,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001655 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,213 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:41 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001535 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,187 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 162 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 15:40 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,053 | $35.66 | $73,217.58 |
DisclosureSEC source: 0001562180-21-002503 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,025 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.41 to $35.94. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 20 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 17:38 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 6,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001356 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,058 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. F3 · balance_after: Column 5 reflects the acquisition of 24 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:04 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 4,968 | $0.00 Strike: $15.69 | $0.00 |
DisclosureSEC source: 0001562180-20-006812 · primarydocument.xml · derivative · entry 5 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242 Underlying: Common Stock · 4,968 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grand and an additional 25% at each ensuing anniversary date. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:04 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 15,000 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001562180-20-006812 · primarydocument.xml · derivative · entry 4 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grand and an additional 25% at each ensuing anniversary date. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:04 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 19,968 | $33.22 | $663,416.83 |
DisclosureSEC source: 0001562180-20-006812 · primarydocument.xml · nonDerivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,578 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.15 to $33.32. The price reported above reflects the weighted average price. F1 · balance_after: Column 5 reflects the acquisition of 31 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:04 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,968 | $15.69 | $77,947.92 |
DisclosureSEC source: 0001562180-20-006812 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Column 5 reflects the acquisition of 31 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:04 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 15,000 | $22.94 | $344,100.00 |
DisclosureSEC source: 0001562180-20-006812 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Column 5 reflects the acquisition of 31 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 23:53 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 30 | $21.42 | $642.60 |
DisclosureSEC source: 0001562180-20-004725 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,547 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:21 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 575 | $18.53 | $10,654.75 |
DisclosureSEC source: 0001562180-20-002768 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,517 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 20:09 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 6,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001546 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,942 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 14:58 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 13 | $24.65 | $320.45 |
DisclosureSEC source: 0001562180-19-006279 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,907 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 21:42 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,000 | $27.49 | $219,923.20 |
DisclosureSEC source: 0001562180-19-005077 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,894 F1 · price: This transaction was executed in multiple trades at prices ranging from $27.29 to $27.82. The price reported above reflects the weighted average price. Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 23:36 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 14 | $23.52 | $329.28 |
DisclosureSEC source: 0001562180-19-004976 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,894 Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 5,640 | $18.30 Strike: $18.30 | $103,212.00 |
DisclosureSEC source: 0001562180-19-004022 · primarydocument.xml · derivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,640 shares Expires 2020-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,640 | $25.32 | $142,804.80 |
DisclosureSEC source: 0001562180-19-004022 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,880 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 22, 2019 Filed Jul 22, 2019 20:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 5,640 | $18.30 | $103,212.00 |
DisclosureSEC source: 0001562180-19-004022 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 18:24 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 15 | $20.92 | $313.80 |
DisclosureSEC source: 0001562180-19-003714 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,880 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 12:26 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 588 | $17.58 | $10,337.04 |
DisclosureSEC source: 0001562180-19-002056 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,865 F3 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 12:26 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 6,920 | $20.54 | $142,147.18 |
DisclosureSEC source: 0001562180-19-002056 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,277 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.41 to $20.62. The price reported above reflects the weighted average price. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 20:00 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 2,686 | $15.41 Strike: $15.41 | $41,391.26 |
DisclosureSEC source: 0001562180-19-001940 · primarydocument.xml · derivative · entry 3 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,686 shares Expires 2019-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 20:00 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,686 | $20.82 | $55,922.52 |
DisclosureSEC source: 0001562180-19-001940 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,197 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 20:00 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 2,686 | $15.41 | $41,391.26 |
DisclosureSEC source: 0001562180-19-001940 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 22:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001280 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,197 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan; pending shareholder approval. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.